Reproductive outcome in patients treated by oral methotrexate or laparoscopic salpingotomy for the management of tubal ectopic pregnancy

To determine the reproductive outcome of women who have received methotrexate or been treated by laparoscopic salpingotomy (LS) for ectopic tubal pregnancy. The study consisted of 123 participants, all women with tubal pregnancies, who had been treated either by methotrexate per os or by laparoscopi...

Full description

Saved in:
Bibliographic Details
Published in:Clinical and experimental obstetrics & gynecology 2006, Vol.33 (2), p.90-92
Main Authors: Dalkalitsis, N, Stefos, T, Kaponis, A, Tsanadis, G, Paschopoulos, M, Dousias, V
Format: Article
Language:English
Subjects:
Abortifacient Agents, Nonsteroidal - therapeutic use
Administration, Oral
Adult
Fallopian Tubes - surgery
Female
Fertility
Follow-Up Studies
Humans
Laparoscopy
Methotrexate - therapeutic use
Pregnancy
Pregnancy Outcome
Pregnancy Rate
Pregnancy, Ectopic - therapy
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To determine the reproductive outcome of women who have received methotrexate or been treated by laparoscopic salpingotomy (LS) for ectopic tubal pregnancy. The study consisted of 123 participants, all women with tubal pregnancies, who had been treated either by methotrexate per os or by laparoscopic salpingotomy. The reproductive outcome of these women was estimated after a follow-up time-period of ten years. In the methotrexate group, consisting of 34 women, the fertility rate was 82% with a mean interval time to conceive of 9.4 months after the treatment. In the group treated by LS, consisting of 89 women, the fertility rate was 82.6% and the mean interval time to conceive was 11.7 months. The reproductive outcome of the women who received either per os treatment of methotrexate or LS for tubal pregnancy, remains high. Both therapeutic methods constitute reliable solutions for managing ectopic pregnancy.
ISSN:0390-6663